HEADER TRANSFERASE 08-JAN-09 3FRZ TITLE CRYSTAL STRUCTURE OF HCV NS5B RNA POLYMERASE IN COMPLEX WITH PF868554 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RNA-DIRECTED RNA POLYMERASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: SEQUENCE DATABASE RESIDUES 2420-2989; COMPND 5 SYNONYM: NS5B, P68; COMPND 6 EC: 2.7.7.48; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS; SOURCE 3 ORGANISM_TAXID: 11105; SOURCE 4 STRAIN: 1B; SOURCE 5 GENE: NS5B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DH5ALPHA KEYWDS VIRAL POLYMERASE, ACETYLATION, APOPTOSIS, ATP-BINDING, CAPSID KEYWDS 2 PROTEIN, CELL MEMBRANE, CYTOPLASM, ENDOPLASMIC RETICULUM, ENVELOPE KEYWDS 3 PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, HELICASE, HOST-VIRUS KEYWDS 4 INTERACTION, HYDROLASE, INTERFERON ANTIVIRAL SYSTEM EVASION, LIPID KEYWDS 5 DROPLET, LIPOPROTEIN, MEMBRANE, METAL-BINDING, MITOCHONDRION, KEYWDS 6 MULTIFUNCTIONAL ENZYME, NUCLEOTIDE-BINDING, NUCLEOTIDYLTRANSFERASE, KEYWDS 7 NUCLEUS, ONCOGENE, PALMITATE, PHOSPHOPROTEIN, PROTEASE, KEYWDS 8 RIBONUCLEOPROTEIN, RNA REPLICATION, RNA-BINDING, RNA-DIRECTED RNA KEYWDS 9 POLYMERASE, SECRETED, SERINE PROTEASE, SH3-BINDING, THIOL PROTEASE, KEYWDS 10 TRANSCRIPTION, TRANSCRIPTION REGULATION, TRANSFERASE, TRANSMEMBRANE, KEYWDS 11 UBL CONJUGATION, VIRAL NUCLEOPROTEIN, VIRION, ZINC EXPDTA X-RAY DIFFRACTION AUTHOR H.E.PARGE REVDAT 4 20-OCT-21 3FRZ 1 REMARK SEQADV LINK REVDAT 3 16-JUN-10 3FRZ 1 JRNL REVDAT 2 24-MAR-09 3FRZ 1 LINK REVDAT 1 10-MAR-09 3FRZ 0 JRNL AUTH H.LI,J.TATLOCK,A.LINTON,J.GONZALEZ,T.JEWELL,L.PATEL, JRNL AUTH 2 S.LUDLUM,M.DROWNS,S.V.RAHAVENDRAN,H.SKOR,R.HUNTER,S.T.SHI, JRNL AUTH 3 K.J.HERLIHY,H.PARGE,M.HICKEY,X.YU,F.CHAU,J.NONOMIYA,C.LEWIS JRNL TITL DISCOVERY OF JRNL TITL 2 (R)-6-CYCLOPENTYL-6-(2-(2,6-DIETHYLPYRIDIN-4-YL)ETHYL) JRNL TITL 3 -3-((5,7-DIMETHYL-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-2-YL) JRNL TITL 4 METHYL)-4-HYDROXY-5,6-DIHYDROPYRAN-2-ONE (PF-00868554) AS A JRNL TITL 5 POTENT AND ORALLY AVAILABLE HEPATITIS C VIRUS POLYMERASE JRNL TITL 6 INHIBITOR. JRNL REF J.MED.CHEM. V. 52 1255 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19209845 JRNL DOI 10.1021/JM8014537 REMARK 2 REMARK 2 RESOLUTION. 1.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.86 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 49603 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2662 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.86 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.91 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3428 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2050 REMARK 3 BIN FREE R VALUE SET COUNT : 190 REMARK 3 BIN FREE R VALUE : 0.2890 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4325 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 69 REMARK 3 SOLVENT ATOMS : 660 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.11000 REMARK 3 B22 (A**2) : -0.11000 REMARK 3 B33 (A**2) : 0.21000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.139 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.135 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.082 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.682 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.964 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.946 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4503 ; 0.017 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 4090 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6120 ; 1.482 ; 1.969 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9481 ; 0.857 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 561 ; 5.516 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 687 ; 0.095 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5000 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 923 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 896 ; 0.212 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 4733 ; 0.250 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 2637 ; 0.085 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 413 ; 0.148 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 6 ; 0.158 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 48 ; 0.235 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 22 ; 0.197 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2805 ; 0.913 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4524 ; 1.661 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1698 ; 2.617 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1596 ; 4.035 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3FRZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-JAN-09. REMARK 100 THE DEPOSITION ID IS D_1000050968. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-AUG-04 REMARK 200 TEMPERATURE (KELVIN) : 101 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-D REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC CONFOCAL OPTICS REMARK 200 OPTICS : OSMIC CONFOCAL OPTICS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52311 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.860 REMARK 200 RESOLUTION RANGE LOW (A) : 10.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 11.98 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03300 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.86 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.3 REMARK 200 DATA REDUNDANCY IN SHELL : 11.90 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.20500 REMARK 200 FOR SHELL : 13.40 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: ARP/WARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: STOCK CRYSTALS GENERATED FROM 2UL REMARK 280 PROTEIN:AG9322(1:5)+ 2UL PRECIPITANT EQUILIBRATED AGAINST REMARK 280 RESERVOIR 18.0% PEG 3K, 0.1M CITRATE PH 5.5, 14% GLYCEROL, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 90.13150 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 41.60000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 41.60000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 45.06575 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 41.60000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 41.60000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 135.19725 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 41.60000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 41.60000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 45.06575 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 41.60000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 41.60000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 135.19725 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 90.13150 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 563 REMARK 465 LEU A 564 REMARK 465 SER A 565 REMARK 465 ARG A 566 REMARK 465 ALA A 567 REMARK 465 ARG A 568 REMARK 465 PRO A 569 REMARK 465 ARG A 570 REMARK 465 HIS A 571 REMARK 465 HIS A 572 REMARK 465 HIS A 573 REMARK 465 HIS A 574 REMARK 465 HIS A 575 REMARK 465 HIS A 576 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 50 CE NZ REMARK 470 LYS A 51 CD CE NZ REMARK 470 LYS A 74 CD CE NZ REMARK 470 LYS A 79 CE NZ REMARK 470 LYS A 81 CD CE NZ REMARK 470 GLU A 86 CG CD OE1 OE2 REMARK 470 LYS A 106 CG CD CE NZ REMARK 470 ARG A 114 NE CZ NH1 NH2 REMARK 470 LYS A 212 CG CD CE NZ REMARK 470 ARG A 222 NE CZ NH1 NH2 REMARK 470 LYS A 379 CE NZ REMARK 470 LYS A 441 CE NZ REMARK 470 LYS A 531 CE NZ REMARK 470 LYS A 535 CG CD CE NZ REMARK 470 GLN A 544 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 823 O HOH A 1127 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 107 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 131 -43.78 -131.06 REMARK 500 LEU A 260 -58.00 -124.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 AG6 A 578 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AG0 A 577 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AG6 A 578 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME A 579 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2HAI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HCV NS5B RNA POLYMERASE IN COMPLEX WITH NOVEL REMARK 900 CLASS OF DIHYDROPYRONE-CONTAINING INHIBITOR. REMARK 900 RELATED ID: 1OS5 RELATED DB: PDB REMARK 900 HCV NS5B COMPLEXED WITH NOVEL NON-COMPETITIVE INHIBITOR DBREF 3FRZ A 1 570 UNP P26663 POLG_HCVBK 2420 2989 SEQADV 3FRZ GLN A 47 UNP P26663 LEU 2466 ENGINEERED MUTATION SEQADV 3FRZ ASP A 59 UNP P26663 VAL 2478 ENGINEERED MUTATION SEQADV 3FRZ TYR A 101 UNP P26663 PHE 2520 ENGINEERED MUTATION SEQADV 3FRZ ARG A 114 UNP P26663 LYS 2533 ENGINEERED MUTATION SEQADV 3FRZ GLN A 544 UNP P26663 ARG 2963 VARIANT SEQADV 3FRZ HIS A 571 UNP P26663 EXPRESSION TAG SEQADV 3FRZ HIS A 572 UNP P26663 EXPRESSION TAG SEQADV 3FRZ HIS A 573 UNP P26663 EXPRESSION TAG SEQADV 3FRZ HIS A 574 UNP P26663 EXPRESSION TAG SEQADV 3FRZ HIS A 575 UNP P26663 EXPRESSION TAG SEQADV 3FRZ HIS A 576 UNP P26663 EXPRESSION TAG SEQRES 1 A 576 SER MET SER TYR THR TRP THR GLY ALA LEU ILE THR PRO SEQRES 2 A 576 CYS ALA ALA GLU GLU SER LYS LEU PRO ILE ASN ALA LEU SEQRES 3 A 576 SER ASN SER LEU LEU ARG HIS HIS ASN MET VAL TYR ALA SEQRES 4 A 576 THR THR SER ARG SER ALA GLY GLN ARG GLN LYS LYS VAL SEQRES 5 A 576 THR PHE ASP ARG LEU GLN ASP LEU ASP ASP HIS TYR ARG SEQRES 6 A 576 ASP VAL LEU LYS GLU MET LYS ALA LYS ALA SER THR VAL SEQRES 7 A 576 LYS ALA LYS LEU LEU SER VAL GLU GLU ALA CYS LYS LEU SEQRES 8 A 576 THR PRO PRO HIS SER ALA LYS SER LYS TYR GLY TYR GLY SEQRES 9 A 576 ALA LYS ASP VAL ARG ASN LEU SER SER ARG ALA VAL ASN SEQRES 10 A 576 HIS ILE HIS SER VAL TRP LYS ASP LEU LEU GLU ASP THR SEQRES 11 A 576 VAL THR PRO ILE ASP THR THR ILE MET ALA LYS ASN GLU SEQRES 12 A 576 VAL PHE CYS VAL GLN PRO GLU LYS GLY GLY ARG LYS PRO SEQRES 13 A 576 ALA ARG LEU ILE VAL PHE PRO ASP LEU GLY VAL ARG VAL SEQRES 14 A 576 CYS GLU LYS MET ALA LEU TYR ASP VAL VAL SER THR LEU SEQRES 15 A 576 PRO GLN VAL VAL MET GLY SER SER TYR GLY PHE GLN TYR SEQRES 16 A 576 SER PRO GLY GLN ARG VAL GLU PHE LEU VAL ASN THR TRP SEQRES 17 A 576 LYS SER LYS LYS ASN PRO MET GLY PHE SER TYR ASP THR SEQRES 18 A 576 ARG CYS PHE ASP SER THR VAL THR GLU ASN ASP ILE ARG SEQRES 19 A 576 VAL GLU GLU SER ILE TYR GLN CYS CYS ASP LEU ALA PRO SEQRES 20 A 576 GLU ALA ARG GLN ALA ILE LYS SER LEU THR GLU ARG LEU SEQRES 21 A 576 TYR ILE GLY GLY PRO LEU THR ASN SER LYS GLY GLN ASN SEQRES 22 A 576 CYS GLY TYR ARG ARG CYS ARG ALA SER GLY VAL LEU THR SEQRES 23 A 576 THR SER CYS GLY ASN THR LEU THR CYS TYR LEU LYS ALA SEQRES 24 A 576 SER ALA ALA CYS ARG ALA ALA LYS LEU GLN ASP CYS THR SEQRES 25 A 576 MET LEU VAL ASN GLY ASP ASP LEU VAL VAL ILE CYS GLU SEQRES 26 A 576 SER ALA GLY THR GLN GLU ASP ALA ALA SER LEU ARG VAL SEQRES 27 A 576 PHE THR GLU ALA MET THR ARG TYR SER ALA PRO PRO GLY SEQRES 28 A 576 ASP PRO PRO GLN PRO GLU TYR ASP LEU GLU LEU ILE THR SEQRES 29 A 576 SER CYS SER SER ASN VAL SER VAL ALA HIS ASP ALA SER SEQRES 30 A 576 GLY LYS ARG VAL TYR TYR LEU THR ARG ASP PRO THR THR SEQRES 31 A 576 PRO LEU ALA ARG ALA ALA TRP GLU THR ALA ARG HIS THR SEQRES 32 A 576 PRO VAL ASN SER TRP LEU GLY ASN ILE ILE MET TYR ALA SEQRES 33 A 576 PRO THR LEU TRP ALA ARG MET ILE LEU MET THR HIS PHE SEQRES 34 A 576 PHE SER ILE LEU LEU ALA GLN GLU GLN LEU GLU LYS ALA SEQRES 35 A 576 LEU ASP CYS GLN ILE TYR GLY ALA CYS TYR SER ILE GLU SEQRES 36 A 576 PRO LEU ASP LEU PRO GLN ILE ILE GLU ARG LEU HIS GLY SEQRES 37 A 576 LEU SER ALA PHE SER LEU HIS SER TYR SER PRO GLY GLU SEQRES 38 A 576 ILE ASN ARG VAL ALA SER CYS LEU ARG LYS LEU GLY VAL SEQRES 39 A 576 PRO PRO LEU ARG VAL TRP ARG HIS ARG ALA ARG SER VAL SEQRES 40 A 576 ARG ALA ARG LEU LEU SER GLN GLY GLY ARG ALA ALA THR SEQRES 41 A 576 CYS GLY LYS TYR LEU PHE ASN TRP ALA VAL LYS THR LYS SEQRES 42 A 576 LEU LYS LEU THR PRO ILE PRO ALA ALA SER GLN LEU ASP SEQRES 43 A 576 LEU SER GLY TRP PHE VAL ALA GLY TYR SER GLY GLY ASP SEQRES 44 A 576 ILE TYR HIS SER LEU SER ARG ALA ARG PRO ARG HIS HIS SEQRES 45 A 576 HIS HIS HIS HIS HET AG0 A 577 37 HET AG6 A 578 28 HET BME A 579 4 HETNAM AG0 (6R)-6-CYCLOPENTYL-6-[2-(2,6-DIETHYLPYRIDIN-4-YL) HETNAM 2 AG0 ETHYL]-3-[(5,7-DIMETHYL[1,2,4]TRIAZOLO[1,5- HETNAM 3 AG0 A]PYRIMIDIN-2-YL)METHYL]-4-HYDROXY-5,6-DIHYDRO-2H- HETNAM 4 AG0 PYRAN-2-ONE HETNAM AG6 N-[(BENZYLOXY)CARBONYL]-L-ALPHA-GLUTAMYL-N-[(1S)-4-OXO- HETNAM 2 AG6 4-PHENYL-1-PROPYLBUT-2-EN-1-YL]-L-PHENYLALANINAMIDE HETNAM BME BETA-MERCAPTOETHANOL FORMUL 2 AG0 C29 H37 N5 O3 FORMUL 3 AG6 C35 H39 N3 O7 FORMUL 4 BME C2 H6 O S FORMUL 5 HOH *660(H2 O) HELIX 1 1 ASN A 24 SER A 29 1 6 HELIX 2 2 HIS A 33 ASN A 35 5 3 HELIX 3 3 THR A 41 ARG A 43 5 3 HELIX 4 4 SER A 44 THR A 53 1 10 HELIX 5 5 ASP A 61 SER A 76 1 16 HELIX 6 6 SER A 84 LEU A 91 1 8 HELIX 7 7 GLY A 104 ASN A 110 1 7 HELIX 8 8 SER A 112 ASP A 129 1 18 HELIX 9 9 ASP A 164 GLY A 188 1 25 HELIX 10 10 SER A 189 TYR A 195 5 7 HELIX 11 11 SER A 196 SER A 210 1 15 HELIX 12 12 CYS A 223 VAL A 228 1 6 HELIX 13 13 THR A 229 CYS A 242 1 14 HELIX 14 14 ALA A 246 LEU A 260 1 15 HELIX 15 15 THR A 286 LYS A 307 1 22 HELIX 16 16 GLY A 328 TYR A 346 1 19 HELIX 17 17 ASP A 359 ILE A 363 5 5 HELIX 18 18 PRO A 388 ARG A 401 1 14 HELIX 19 19 SER A 407 TYR A 415 1 9 HELIX 20 20 THR A 418 ILE A 424 1 7 HELIX 21 21 ILE A 424 GLU A 437 1 14 HELIX 22 22 GLU A 455 LEU A 457 5 3 HELIX 23 23 ASP A 458 GLY A 468 1 11 HELIX 24 24 LEU A 469 SER A 473 5 5 HELIX 25 25 SER A 478 GLY A 493 1 16 HELIX 26 26 PRO A 496 GLY A 515 1 20 HELIX 27 27 GLY A 515 PHE A 526 1 12 HELIX 28 28 ASN A 527 VAL A 530 5 4 HELIX 29 29 ILE A 539 GLN A 544 1 6 HELIX 30 30 LEU A 547 PHE A 551 5 5 SHEET 1 A 5 TYR A 4 TRP A 6 0 SHEET 2 A 5 ASN A 273 ARG A 277 -1 O TYR A 276 N THR A 5 SHEET 3 A 5 GLY A 264 THR A 267 -1 N LEU A 266 O CYS A 274 SHEET 4 A 5 THR A 136 ALA A 140 1 N THR A 136 O THR A 267 SHEET 5 A 5 LEU A 159 PHE A 162 -1 O PHE A 162 N THR A 137 SHEET 1 B 2 VAL A 37 ALA A 39 0 SHEET 2 B 2 VAL A 144 CYS A 146 -1 O PHE A 145 N TYR A 38 SHEET 1 C 3 PRO A 214 TYR A 219 0 SHEET 2 C 3 ASP A 319 GLU A 325 -1 O CYS A 324 N MET A 215 SHEET 3 C 3 GLN A 309 ASN A 316 -1 N GLN A 309 O GLU A 325 SHEET 1 D 2 ASN A 369 HIS A 374 0 SHEET 2 D 2 ARG A 380 THR A 385 -1 O VAL A 381 N ALA A 373 SHEET 1 E 2 LEU A 443 ILE A 447 0 SHEET 2 E 2 ALA A 450 ILE A 454 -1 O ILE A 454 N LEU A 443 SSBOND 1 CYS A 303 CYS A 311 1555 1555 2.05 LINK SG CYS A 14 C15 AG6 A 578 1555 1555 1.82 LINK SG CYS A 223 S2 BME A 579 1555 1555 2.11 SITE 1 AC1 12 LYS A 270 LEU A 419 ARG A 422 MET A 423 SITE 2 AC1 12 HIS A 475 SER A 476 ILE A 482 ARG A 501 SITE 3 AC1 12 HOH A 659 HOH A 677 HOH A 842 HOH A1154 SITE 1 AC2 5 CYS A 14 LYS A 98 PRO A 479 HOH A 655 SITE 2 AC2 5 HOH A 824 SITE 1 AC3 2 ARG A 48 CYS A 223 CRYST1 83.200 83.200 180.263 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012019 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012019 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005547 0.00000